EverZom

EverZom is a biotech company in Paris, France, founded in 2019. It has raised $11.7M across 1 round, most recently an $11.7M Series A in October 2025.

Exosome biotech company

Headquarters
Paris
Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$11.7M
Last Round
$11.7M Series AOct 2025
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round for this company. The full record is or through the API.

About

EVerZom is a Paris-based biotech company producing exosome-based regenerative therapies. Founded in September 2019 (originating from patent work at Université de Paris/CNRS and Genethon starting in 2017), the company developed a patented, high-yield, large-scale exosome production platform targeting digestive tissue healing, fistula treatment, and organ regeneration. EVerZom has won multiple innovation awards, including the European EIC Accelerator, and raised €10 million to advance its therapies toward clinical development.

Summary

It lists 11–50 employees. It has raised $11.7M in total across 1 round, most recently a $11.7M Series A round in Oct 2025.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries AOct 2025
$11.7M

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

EverZom on Indexed.vc
<a href="https://indexed.vc/companies/everzom"><img src="https://indexed.vc/api/badge/company/everzom" alt="EverZom on Indexed.vc" width="260" height="76" /></a>